Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United States Antimony (UAMY) EBT (2016 - 2025)

Historic EBT for United States Antimony (UAMY) over the last 16 years, with Q3 2025 value amounting to -$4.8 million.

  • United States Antimony's EBT fell 55005.5% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year increase of 3674.69%. This contributed to the annual value of -$1.7 million for FY2024, which is 7287.03% up from last year.
  • United States Antimony's EBT amounted to -$4.8 million in Q3 2025, which was down 55005.5% from $336325.0 recorded in Q2 2025.
  • United States Antimony's 5-year EBT high stood at $779580.0 for Q1 2022, and its period low was -$6.4 million during Q4 2023.
  • Its 5-year average for EBT is -$701812.1, with a median of -$187075.0 in 2023.
  • As far as peak fluctuations go, United States Antimony's EBT tumbled by 227470.49% in 2022, and later soared by 130021.99% in 2024.
  • United States Antimony's EBT (Quarter) stood at $37110.0 in 2021, then tumbled by 2274.7% to -$807033.0 in 2022, then tumbled by 697.47% to -$6.4 million in 2023, then skyrocketed by 86.37% to -$877331.0 in 2024, then plummeted by 443.31% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, $336325.0 for Q2 2025, and $738680.0 during Q1 2025.